Mode
Text Size
Log in / Sign up

Surgical excision of submandibular masses successfully normalized PTH levels in patients with recurrent secondary hyperparathyroidismTiny Study Finds Missed Parathyroid Glands in Dialysis Patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that surgical excision of submandibular masses can normalize PTH in cases of recurrent secondary hyperparathyroidism.

This case series and literature review explores the management of recurrent secondary hyperparathyroidism in patients on maintenance dialysis. The authors focus on the identification and surgical excision of submandibular masses as a treatment for persistent parathyroid hormone elevation.

In the series of 3 patients, surgical excision of submandibular masses resulted in PTH levels returning to the normal range in 3/3 cases. Additionally, clinical symptoms improved markedly in all 3 patients. The authors identify ectopic submandibular parathyroid glands as the specific cause of recurrent PTH elevation in these cases.

The authors note that the study is limited by a small sample size of 3 cases. While the findings suggest the utility of 99mTc-MIBI SPECT/CT for identifying ectopic glands, the rarity of these glands and the specific efficacy of the imaging modality are not established by this data. Clinical application should be approached with caution due to the low certainty of evidence.

If you're on dialysis and your parathyroid hormone levels won't stay down after surgery, the problem might not be your parathyroid gland at all. It could be a tiny piece of parathyroid tissue hiding somewhere unexpected, like your jaw.

A new case series describes three patients on maintenance dialysis who had recurrent secondary hyperparathyroidism, meaning their parathyroid hormone levels kept rising even after they'd already had surgery to remove parathyroid glands. When doctors used a specific imaging scan called 99mTc-MIBI SPECT/CT, they found ectopic parathyroid glands, tissue that had settled in the submandibular area, near the jaw. All three patients had another surgery to remove these masses. Afterward, their parathyroid hormone levels returned to normal, and their symptoms improved markedly.

The follow-up ranged from 3 to 37 months after the initial parathyroidectomy. The study highlights how important this imaging technique can be for finding these misplaced glands in cases of recurrent disease.

But there's a big caveat: this is a case series with only three patients. That's a very small sample size, and it means we can't draw firm conclusions about how well this approach works for everyone. The findings are low certainty. Still, for the three people involved, the outcome was a return to normal hormone levels and better symptoms.

What this means for you:
In three dialysis patients, hidden parathyroid glands in the jaw caused recurring hormone spikes. Surgery fixed it.

Common questions

What is secondary hyperparathyroidism?

It's a condition where your parathyroid glands make too much parathyroid hormone (PTH). This often happens in people with kidney failure on dialysis. The extra PTH can cause bone problems and other issues. In this study, patients had recurrent secondary hyperparathyroidism, meaning their PTH levels went up again after initial treatment.

How common are ectopic submandibular parathyroid glands?

The study notes they are rare. Ectopic means the gland is in an unusual spot, like the submandibular area near the jaw, instead of its normal place. This case series found them in three dialysis patients with recurrent high PTH. Because it's so rare, doctors may not think to look there first.

What imaging test helps find these hidden glands?

The study highlights 99mTc-MIBI SPECT/CT. This scan combines two types of imaging to locate parathyroid tissue. In these three cases, it identified the ectopic glands in the submandibular region. That helped surgeons remove them. The authors say this imaging is important for finding such glands when PTH levels rise again.

Did surgery fix the problem for these patients?

Yes, for all three patients. After surgery to remove the submandibular masses, their PTH levels returned to the normal range. Their clinical symptoms also improved markedly. Follow-up ranged from 3 to 37 months after the first parathyroidectomy. However, this is a very small study, so results may not apply to everyone.

What are the limitations of this study?

The main limitation is the tiny sample size: only three cases. That makes the evidence low certainty. We can't say how often this approach works or who might benefit most. The study also doesn't report safety data like side effects. Talk to your doctor about your own situation.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Postoperative recurrence for secondary hyperparathyroidism (SHPT) remains a clinical challenge. Ectopic parathyroid glands are a major cause of recurrence, and those located in the submandibular region are rare. This report retrospectively analyzes three patients on maintenance dialysis who developed recurrent elevation of parathyroid hormone (PTH) levels 3 to 37 months after parathyroidectomy (PTX) for SHPT. Neck ultrasound revealed no definite lesions; however, 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) single-photon emission computed tomography/computed tomography (SPECT/CT) fusion imaging showed abnormal radioactive tracer uptake in the submandibular region, suggestive of ectopic parathyroid glands. All three patients underwent a second or multiple surgeries, with complete excision of the submandibular masses. Postoperative pathology confirmed parathyroid tissue. After surgery, PTH levels returned to the normal range, and clinical symptoms improved markedly. Combined with a literature review, this article discusses the causes of recurrence after SHPT surgery, the anatomical basis of ectopic lesions in the submandibular region, and the localization diagnosis and treatment strategies for ectopic parathyroid glands, aiming to improve clinical awareness of such rare cases.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.